No Data
Weak Statutory Earnings May Not Tell The Whole Story For Tellgen (SZSE:300642)
Perspective Life: Report for the third quarter of 2024
Tellgen Corporation (300642.SZ) released its performance for the first half of the year, with a net income of 24.3929 million yuan, a year-on-year decrease of 43.16%.
Tellgen Corporation (300642.SZ) released the third quarter report for 2024, with revenue of 3....
tellgen corporation (300642.SZ): net income in the third quarter was 17.7589 million yuan, a year-on-year increase of 120.53%.
On October 24, Guilonghui announced that in the third quarter of 2024, Tellgen Corporation (300642.SZ) achieved revenue of 0.105 billion yuan, a 15.92% year-on-year decrease; net income attributable to shareholders of the listed company was 17.7589 million yuan, an increase of 120.53% year-on-year; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 11.2616 million yuan, an increase of 491.28% year-on-year; and basic earnings per share was 0.1094 yuan.
Calculating The Intrinsic Value Of Tellgen Corporation (SZSE:300642)
Tellgen Corporation (300642.SZ): Subsidiary's application for medical instruments registration has been accepted.
Tellgen Corporation (300642.SZ) announced that its wholly-owned subsidiary jiangxi tellgen Technology Co., Ltd. ("jiangxi...
Need To Know: Analysts Just Made A Substantial Cut To Their Tellgen Corporation (SZSE:300642) EstimatesNo Data
No Data
